Psychiatric Disorders

Psychiatry

9 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
Transdermal cannabidiol therapies (Zynerba)	Harmony Biosciences Holdings, Inc. (HRMY)

Phase 2(1)

Drug	Company
ABP-450 (prabotulinumtoxinA)	AEON Biopharma, Inc. (AEON)

Phase 1(4)

Drug	Company
aripiprazole tds	Corium International, Inc. (CORI)
ITI-1549	Intra-Cellular Therapies, Inc. (ITCI)
ORX142	Centessa Pharmaceuticals plc (CNTA)
ORX489	Centessa Pharmaceuticals plc (CNTA)

Preclinical(3)

Drug	Company
eb-002	Enveric Biosciences, Inc. (ENVB)
kv7 development candidates	Xenon Pharmaceuticals Inc. (XENE)
novel cannabinoid therapeutic	Greater Cannabis Company, Inc. (GCAN)

BioSniper tracks 9 drugs in development for Psychiatric Disorders across 8 companies.

There are 1 clinical trial targeting Psychiatric Disorders tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.